1 / 76

Generic Country Markets & Biosimilars

Generic Country Markets & Biosimilars. Chesapeake Dr. Brian W Tempest www.briantempest.com brian.tempest@clara.co.uk UK March 2014. 7. Generic Country Markets. Europe source: EGA. Reference Pricing Globally Endemic Source : Istanbul September 2012.

hercules-pasha
Télécharger la présentation

Generic Country Markets & Biosimilars

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Generic Country Markets & Biosimilars Chesapeake Dr. Brian W Tempest www.briantempest.com brian.tempest@clara.co.uk UK March 2014

  2. 7. Generic Country Markets

  3. Europesource: EGA

  4. Reference Pricing Globally Endemic Source : Istanbul September 2012 • Pharma purchases reduced from 1.7% of GDP to 1.0% of GDP in Turkey • Russia, South Korea & Saudi Arabia health ministries requested Turkish prices • Everybody is referencing everybody else on Pharma prices in Europe • Bulgaria is referencing prices in 17 other countries

  5. Europe – generics take half the volume but a fraction of value sales

  6. EU Chemical Salessource: Chemistry World September 2013

  7. Open letter to Barroso from the Chairman of INEOS on 7 March 2014

  8. Generic Global Volume Share Source: Sandoz

  9. 30 generic packs, >2 years treatment £69200 king size cigarettes £68Source: Generics Bulletin 15 Feb 2013

  10. European Generic Prices Source Ranbaxy

  11. Indian Pharma penetration of the UKsource: FT January 13 2014

  12. Security of Power Supplies in Europesource: Economist 15 April 2014

  13. France Generic MarketSource: Generics Bulletin 15 February 2013

  14. US DMFs from Indiasource: Citi Research 2013

  15. Number of USA Para IVssource: Generics Bulletin 14 September 2012, quarter indian

  16. USA Generic Market - Latest Challengessource: Jefferies 10 March 2014

  17. Africa Management source Ranbaxy

  18. Nigeria, South Africa & Angolasource: Economist 12 April 2014

  19. African Factories

  20. Japan Generic Marketsource: Citi Research August 2013

  21. Japan Generic Opportunity

  22. Japanese Generic Marketsource: Mint 28 January 2014

  23. Brazil Generic Packs

  24. Brazil Top 10 Generic Cos

  25. Russia 2020 Strategy for Public Health

  26. Russian Market Evolutionsource: Frost & Sullivan 2011

  27. Vaccine Plant to take 1/3 Russian Market source: St Petersburg Times, 16 April 2014

  28. USA Generic Market - Latest Challengessource: Jefferies 10 March 2014

  29. Russia VLS List

  30. Russia 2020 Strategy 90% local manufacture of VLS list

  31. Russia 2020 Strategy 50% local manufacture of all products

  32. New Novartis Plant in St Petersburgsource: Top Emerging Pharmaceutical Markets by Kathlyn Stone

  33. Russia & India – Big Picturesource: ET March 26 2014

  34. Russia & India – Big Picturesource: ET March 26 2014

  35. Indian Pharma in Russia - DRLsource: website, 20 years

  36. Indian Pharma in Russia - Ranbaxysource: RUR, 20 years, 15% MS IMS May 2013, across 56 Regions

  37. Chinese Debt 200% of GDP in 2013source: FT 2 April 2014

  38. Chinese NGOssource: Economist 12 April 2014

  39. China Pharma Industry Capex Plans Source: Stravencom

  40. China Price Cutssource: Jefferies

  41. China API Exports decline by -9%source: Pharmatiimes February 21 2014

  42. Hisun Pfizer Pharmaceuticals Ltdsource: Launch Announcement September 12 2013

  43. Hisun USAsource: website

  44. Hisun USA acquires FDA approved DPIsource: Press Release January 17 2012

  45. Hisun USA acquires FDA approved DPIsource: Press Release January 17 2012

  46. China: Optimistic view of Domestic Marketsource: Jefferies 17 March 2014

  47. China Provincial Tenderssource: Jefferies 17 March 2014

  48. Sino Biopharm strongest domestic pipeline source: Jefferies March 17 2014

  49. Zhejiang Huahai(Novast also received an ANDA for an OC in 2010)

  50. China - Actavis Withdrawssource: Bloomberg January 15 2014

More Related